| Financial Year |
March 31 2023 |
| Monetary Funds |
403,567,113.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
129,849,709.61 |
| Advances to Suppliers |
7,722,938.63 |
| Other Receivables |
2,027,734.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,560,601.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,979,419.28 |
| Total Current Assets |
699,766,892.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,784,061.83 |
| Investment Properties |
-- |
| Fixed Assetes |
191,715,187.97 |
| Under-construction Projects |
18,402,377.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,134,730.66 |
| R&D expenses |
-- |
| Goodwill |
9,327,073.65 |
| Long-Term Deferred and Prepaid Expenses |
1,722,093.48 |
| Deferred Income Tax Assets |
11,013,079.59 |
| Other Non-Current Assets |
14,865,995.22 |
| Sub-Total of Non-Current Assets |
673,684,377.45 |
| Total Assets |
1,373,451,270.06 |
| Short-Term Loans |
9,909,680.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,015,110.29 |
| Accounts Payable |
74,807,145.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,570,824.38 |
| Taxes Payable |
13,369,914.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,769,544.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,876,632.72 |
| Other Current Liabilities |
51,172.25 |
| Sub-Total of Current Liabilities |
132,774,100.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,933,255.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
47,613,547.85 |
| Total Liabilities |
180,387,648.80 |
| Paid-In Capital(Or Share Stock) |
348,000,000.00 |
| Capital Surplus |
56,519,080.39 |
| Surplus Reserve |
128,448,606.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
625,430,723.55 |
| Minority Stockholder's Interest |
34,781,255.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,158,282,365.51 |
| Owner's Equity（Stockholder's Equity） |
1,193,063,621.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,373,451,270.06 |
